4-methylsalinomycin,
narasin,
narasin A,
narasin monosodium salt,
narasin,
Narasin A,
Monteban,
Compound 79891,
Antibiotic C 7819B,
Antibiotic A 28086A,
Narasine [INN-French],
Narasinum [INN-Latin],
Narasino [INN-Spanish],
UNII-DZY9VU539P,
C 7819B,
A 28086A,
Antibiotic A-28086 factor A,
4-Methylsalinomycin,
BRN 1678311,
DZY9VU539P,
Narasine,
Narasino,
Narasinum,
AI3-29798,
Lilly 79891,
Salinomycin, 4-methyl-, (4S),
55134-13-9,
Narasin [USAN:BAN:INN],
Narasul,
alpha-Ethyl-6-(5-(2-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro(4.1.5.3)pentadec-13-en-9-yl)-2-hydroxy-1,3-dimethyl-4-oxoheptyl)tetrahydro-3,5-dimethyl-2H-pyran-2-acetic acid,
Monteban (TN),
Narasin (USP/INN),
2H-Pyran-2-acetic acid, alpha-ethyl-6-(5-(2-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro(4.1.5.3)pentadec-13-en-9-yl)-2-hydroxy-1,3-dimethyl-4-oxoheptyl)tetrahydro-3,5-dimethyl-,
(4S)-4-Methylsalinomycin,
Narasin [USAN:USP:INN:BAN],
NCGC00167550-01,
C43H72O11,
DSSTox_CID_26707,
DSSTox_RID_81840,
DSSTox_GSID_46707,
SCHEMBL123401,
AC1L23A4,
CHEMBL2104423,
DTXSID2046707,
(4''S'')-4-methyl-salinomycin,
Tox21_112545,
ZINC85540282,
CAS-55134-13-9,
LS-144430,
D05122,
(2R)-2-[(2R,3S,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.5^{7}.3^{5}]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic acid,
Maxiban 72,
Narasin [USAN:INN:BAN],
Salinomycin, 4-methyl-, (4S)-,
CID65452,
Narasin from Streptomyces auriofaciens,
C43-H72-O11,